Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Risk Factors for Household Vector Abundance Using Indoor CDC Light Traps in a High Malaria Transmission Area of Northern Zambia.

Hast MA, Stevenson JC, Muleba M, Chaponda M, Kabuya JB, Mulenga M, Lessler J, Shields T, Moss WJ, Norris DE, For The Southern And Central Africa International Centers Of Excellence In Malaria Research.

Am J Trop Med Hyg. 2019 May 6. doi: 10.4269/ajtmh.18-0875. [Epub ahead of print]

PMID:
31074411
2.

The impact of three years of targeted IRS with pirimiphos-methyl on malaria parasite prevalence in a high-transmission area of northern Zambia.

Hast MA, Chaponda M, Muleba M, Kabuya JB, Lupiya J, Kobayashi T, Shields T, Lessler J, Mulenga M, Stevenson JC, Norris DE, Moss WJ.

Am J Epidemiol. 2019 May 7. pii: kwz107. doi: 10.1093/aje/kwz107. [Epub ahead of print]

PMID:
31062839
3.

Epidemiological and histopathological profile of malignant melanoma in Malawi.

Mulenga M, Montgomery ND, Chagomerana M, Mzumala T, Tomoka T, Kampani C, Fedoriw Y, Gopal S, Sviland L.

BMC Clin Pathol. 2019 Apr 2;19:5. doi: 10.1186/s12907-019-0087-6. eCollection 2019.

4.

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study.

Nambozi M, Tinto H, Mwapasa V, Tagbor H, Kabuya JB, Hachizovu S, Traoré M, Valea I, Tahita MC, Ampofo G, Buyze J, Ravinetto R, Arango D, Thriemer K, Mulenga M, van Geertruyden JP, D'Alessandro U.

Malar J. 2019 Mar 28;18(1):105. doi: 10.1186/s12936-019-2737-7.

5.

Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe.

Kobayashi T, Jain A, Liang L, Obiero JM, Hamapumbu H, Stevenson JC, Thuma PE, Lupiya J, Chaponda M, Mulenga M, Mamini E, Mharakurwa S, Gwanzura L, Munyati S, Mutambu S, Felgner P, Davies DH, Moss WJ.

mSphere. 2019 Mar 27;4(2). pii: e00061-19. doi: 10.1128/mSphereDirect.00061-19.

6.

Prevalence of Trachoma in 47 Administrative Districts of Zambia: Results of 32 Population-Based Prevalence Surveys.

Mwale C, Mumbi W, Funjika M, Sokesi T, Silumesii A, Mulenga M, Mutati G, Kwendakwema D, Chelu C, Adamu Y, Alemayehu W, Al-Khatib T, Bakhtiari A, Dejene M, Massae PA, Mpyet C, Nwosu C, Willis R, Courtright P, Solomon AW.

Ophthalmic Epidemiol. 2018 Dec;25(sup1):171-180. doi: 10.1080/09286586.2018.1546880.

7.

Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi.

Painschab MS, Westmoreland KD, Kasonkanji E, Zuze T, Kaimila B, Waswa P, El-Mallawany NK, Tomoka T, Mulenga M, Montgomery ND, Fedoriw Y, Gopal S.

Blood Adv. 2019 Feb 26;3(4):612-620. doi: 10.1182/bloodadvances.2018029199.

8.

The Search for Plasmodium falciparum histidine-rich protein 2/3 Deletions in Zambia and Implications for Plasmodium falciparum histidine-rich protein 2-Based Rapid Diagnostic Tests.

Kobayashi T, Sikalima J, Parr JB, Chaponda M, Stevenson JC, Thuma PE, Mulenga M, Meshnick SR, Moss WJ, For The Southern And Central Africa International Centers Of Excellence For Malaria Research.

Am J Trop Med Hyg. 2019 Apr;100(4):842-845. doi: 10.4269/ajtmh.18-0859.

PMID:
30719965
9.

The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa.

Unger H, Thriemer K, Ley B, Tinto H, Traoré M, Valea I, Tagbor H, Antwi G, Gbekor P, Nambozi M, Kabuya JB, Mulenga M, Mwapasa V, Chapotera G, Madanitsa M, Rulisa S, de Crop M, Claeys Y, Ravinetto R, D'Alessandro U.

BMC Pregnancy Childbirth. 2019 Jan 8;19(1):12. doi: 10.1186/s12884-018-2128-z.

10.

A saliva-based rapid test to quantify the infectious subclinical malaria parasite reservoir.

Tao D, McGill B, Hamerly T, Kobayashi T, Khare P, Dziedzic A, Leski T, Holtz A, Shull B, Jedlicka AE, Walzer A, Slowey PD, Slowey CC, Nsango SE, Stenger DA, Chaponda M, Mulenga M, Jacobsen KH, Sullivan DJ, Ryan SJ, Ansumana R, Moss WJ, Morlais I, Dinglasan RR.

Sci Transl Med. 2019 Jan 2;11(473). pii: eaan4479. doi: 10.1126/scitranslmed.aan4479.

11.

Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.

Painschab MS, Kasonkanji E, Zuze T, Kaimila B, Tomoka T, Nyasosela R, Nyirenda R, Dhungel BM, Mulenga M, Chikasema M, Tewete B, Mtangwanika A, Chiyoyola S, Mhango W, Chimzimu F, Kampani C, Krysiak R, Shea TC, Montgomery ND, Fedoriw Y, Gopal S.

Br J Haematol. 2019 Feb;184(3):364-372. doi: 10.1111/bjh.15625. Epub 2018 Nov 18.

PMID:
30450671
12.

A prospective description of HIV-associated multicentric Castleman disease in Malawi.

Tomoka T, Painschab MS, Montgomery ND, Seguin R, Mulenga M, Kaimila B, Kasonkanji E, Zuze T, Nyasosela R, Nyirenda R, Chikasema M, Tewete B, Mtangwanika A, Chiyoyola S, Chimzimu F, Kampani C, Fedoriw Y, Gopal S.

Haematologica. 2019 May;104(5):e215-e217. doi: 10.3324/haematol.2018.204479. Epub 2018 Nov 15. No abstract available.

13.

'Discovering' primary effusion lymphoma in Malawi.

Dhungel BM, Montgomery ND, Painschab MS, Mulenga M, Tomoka T, Kaimila B, Zuze T, Kasonkanji E, Kampani C, Chimzimu F, Randall C, Krysiak R, Seguin R, Fedoriw Y, Gopal S.

AIDS. 2018 Sep 24;32(15):2264-2266. doi: 10.1097/QAD.0000000000001933. No abstract available.

PMID:
30212407
14.

Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi.

Horner MJ, Salima A, Chilima C, Mukatipa M, Kumwenda W, Kampani C, Chimzimu F, Mukunda B, Tomoka T, Mulenga M, Nyasosela R, Chasimpha S, Dzamalala C, Gopal S.

J Glob Oncol. 2018 Jul;4:1-11. doi: 10.1200/JGO.17.00174.

15.

Plasmablastic lymphoma in Malawi.

Zuze T, Painschab MS, Seguin R, Kudowa E, Kaimila B, Kasonkanji E, Tomoka T, Dhungel BM, Mulenga M, Chikasema M, Tewete B, Ntangwanika A, Chiyoyola S, Chimzimu F, Kampani C, Krysiak R, Montgomery ND, Fedoriw Y, Gopal S.

Infect Agent Cancer. 2018 Jun 28;13:22. doi: 10.1186/s13027-018-0195-4. eCollection 2018.

16.

RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally.

Pringle JC, Carpi G, Almagro-Garcia J, Zhu SJ, Kobayashi T, Mulenga M, Bobanga T, Chaponda M, Moss WJ, Norris DE.

Sci Rep. 2018 Apr 26;8(1):6622. doi: 10.1038/s41598-018-24585-8.

17.

Risk Factors for Mortality in Children Hospitalized with Severe Malaria in Northern Zambia: A Retrospective Case-Control Study.

Ippolito MM, Kamavu LK, Kabuya JB, Tente C, Chileshe E, Wapachole M, Thuma PE, Muleba M, Chaponda M, Mulenga M, Moss WJ, For The Southern And Central Africa International Centers Of Excellence For Malaria Research.

Am J Trop Med Hyg. 2018 Jun;98(6):1699-1704. doi: 10.4269/ajtmh.17-1017. Epub 2018 Apr 19.

18.

Lymphoma and Pathology in Sub-Saharan Africa: Current Approaches and Future Directions.

Tomoka T, Montgomery ND, Powers E, Dhungel BM, Morgan EA, Mulenga M, Gopal S, Fedoriw Y.

Clin Lab Med. 2018 Mar;38(1):91-100. doi: 10.1016/j.cll.2017.10.007. Epub 2017 Dec 13. Review.

19.

Practical Successes in Telepathology Experiences in Africa.

Montgomery ND, Tomoka T, Krysiak R, Powers E, Mulenga M, Kampani C, Chimzimu F, Owino MK, Dhungel BM, Gopal S, Fedoriw Y.

Clin Lab Med. 2018 Mar;38(1):141-150. doi: 10.1016/j.cll.2017.10.011. Epub 2017 Dec 6. Review.

20.

Malaria knowledge and bed net use in three transmission settings in southern Africa.

Kanyangarara M, Hamapumbu H, Mamini E, Lupiya J, Stevenson JC, Mharakurwa S, Chaponda M, Thuma PE, Gwanzura L, Munyati S, Mulenga M, Norris DE, Moss WJ; Southern Africa International Centers of Excellence for Malaria Research.

Malar J. 2018 Jan 19;17(1):41. doi: 10.1186/s12936-018-2178-8.

21.

Factors associated with postnatal care for newborns in Zambia: analysis of the 2013-14 Zambia demographic and health survey.

Bwalya BB, Mulenga MC, Mulenga JN.

BMC Pregnancy Childbirth. 2017 Dec 13;17(1):418. doi: 10.1186/s12884-017-1612-1.

22.

Enabling the sustainable Faecal Sludge Management service delivery chain-A case study of dense settlements in Kigali, Rwanda.

Akumuntu JB, Wehn U, Mulenga M, Brdjanovic D.

Int J Hyg Environ Health. 2017 Aug;220(6):960-973. doi: 10.1016/j.ijheh.2017.05.001. Epub 2017 May 23.

PMID:
28596087
23.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Auld AF, Shiraishi RW, Oboho I, Ross C, Bateganya M, Pelletier V, Dee J, Francois K, Duval N, Antoine M, Delcher C, Desforges G, Griswold M, Domercant JW, Joseph N, Deyde V, Desir Y, Van Onacker JD, Robin E, Chun H, Zulu I, Pathmanathan I, Dokubo EK, Lloyd S, Pati R, Kaplan J, Raizes E, Spira T, Mitruka K, Couto A, Gudo ES, Mbofana F, Briggs M, Alfredo C, Xavier C, Vergara A, Hamunime N, Agolory S, Mutandi G, Shoopala NN, Sawadogo S, Baughman AL, Bashorun A, Dalhatu I, Swaminathan M, Onotu D, Odafe S, Abiri OO, Debem HH, Tomlinson H, Okello V, Preko P, Ao T, Ryan C, Bicego G, Ehrenkranz P, Kamiru H, Nuwagaba-Biribonwoha H, Kwesigabo G, Ramadhani AA, Ng'wangu K, Swai P, Mfaume M, Gongo R, Carpenter D, Mastro TD, Hamilton C, Denison J, Wabwire-Mangen F, Koole O, Torpey K, Williams SG, Colebunders R, Kalamya JN, Namale A, Adler MR, Mugisa B, Gupta S, Tsui S, van Praag E, Nguyen DB, Lyss S, Le Y, Abdul-Quader AS, Do NT, Mulenga M, Hachizovu S, Mugurungi O, Barr BAT, Gonese E, Mutasa-Apollo T, Balachandra S, Behel S, Bingham T, Mackellar D, Lowrance D, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):558-563. doi: 10.15585/mmwr.mm6621a3.

24.

Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.

Nambozi M, Kabuya JB, Hachizovu S, Mwakazanga D, Mulenga J, Kasongo W, Buyze J, Mulenga M, Van Geertruyden JP, D'Alessandro U.

Malar J. 2017 May 16;16(1):199. doi: 10.1186/s12936-017-1851-7.

25.

Hypertension management in rural primary care facilities in Zambia: a mixed methods study.

Yan LD, Chirwa C, Chi BH, Bosomprah S, Sindano N, Mwanza M, Musatwe D, Mulenga M, Chilengi R.

BMC Health Serv Res. 2017 Feb 3;17(1):111. doi: 10.1186/s12913-017-2063-0.

26.

The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia.

Mwanza S, Joshi S, Nambozi M, Chileshe J, Malunga P, Kabuya JB, Hachizovu S, Manyando C, Mulenga M, Laufer M.

Malar J. 2016 Dec 5;15(1):584.

27.

Four artemisinin-based treatments in African pregnant women with malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

Malawi Med J. 2016 Sep;28(3):139-149.

28.

Qualitative analysis of a psychological supportive counseling group for burn survivors and families in Malawi.

Barnett BS, Mulenga M, Kiser MM, Charles AG.

Burns. 2017 May;43(3):602-607. doi: 10.1016/j.burns.2016.09.027. Epub 2016 Oct 12.

29.

Spatio-temporal heterogeneity of malaria vectors in northern Zambia: implications for vector control.

Stevenson JC, Pinchoff J, Muleba M, Lupiya J, Chilusu H, Mwelwa I, Mbewe D, Simubali L, Jones CM, Chaponda M, Coetzee M, Mulenga M, Pringle JC, Shields T, Curriero FC, Norris DE; Southern Africa International Centers of Excellence in Malaria Research.

Parasit Vectors. 2016 Sep 21;9(1):510.

30.

Individual and Household Level Risk Factors Associated with Malaria in Nchelenge District, a Region with Perennial Transmission: A Serial Cross-Sectional Study from 2012 to 2015.

Pinchoff J, Chaponda M, Shields TM, Sichivula J, Muleba M, Mulenga M, Kobayashi T, Curriero FC, Moss WJ; Southern Africa International Centers of Excellence for Malaria Research.

PLoS One. 2016 Jun 9;11(6):e0156717. doi: 10.1371/journal.pone.0156717. eCollection 2016.

31.

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.

PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D'Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.

N Engl J Med. 2016 Mar 10;374(10):913-27. doi: 10.1056/NEJMoa1508606.

32.

Mounting evidence for use of artemisinin derivatives for malaria in early pregnancy.

Mulenga M, Manyando C.

Lancet Infect Dis. 2016 May;16(5):513-515. doi: 10.1016/S1473-3099(16)00019-0. Epub 2016 Feb 8. No abstract available.

33.

Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia.

Koole O, Denison JA, Menten J, Tsui S, Wabwire-Mangen F, Kwesigabo G, Mulenga M, Auld A, Agolory S, Mukadi YD, van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Bangsberg DR, Colebunders R.

PLoS One. 2016 Jan 20;11(1):e0147309. doi: 10.1371/journal.pone.0147309. eCollection 2016.

34.

Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.

Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F; MSAE, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1281-6. doi: 10.15585/mmwr.mm6446a2.

35.

Predictive Malaria Risk and Uncertainty Mapping in Nchelenge District, Zambia: Evidence of Widespread, Persistent Risk and Implications for Targeted Interventions.

Pinchoff J, Chaponda M, Shields T, Lupiya J, Kobayashi T, Mulenga M, Moss WJ, Curriero FC; Southern Africa International Centers of Excellence for Malaria Research.

Am J Trop Med Hyg. 2015 Dec;93(6):1260-7. doi: 10.4269/ajtmh.15-0283. Epub 2015 Sep 28.

36.
37.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
38.

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.

Denison JA, Koole O, Tsui S, Menten J, Torpey K, van Praag E, Mukadi YD, Colebunders R, Auld AF, Agolory S, Kaplan JE, Mulenga M, Kwesigabo GP, Wabwire-Mangen F, Bangsberg DR.

AIDS. 2015 Jan 28;29(3):361-71. doi: 10.1097/QAD.0000000000000543.

39.

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.

Nambozi M, Mulenga M, Halidou T, Tagbor H, Mwapasa V, Phiri LK, Kalanda G, Valea I, Traore M, Mwakazanga D, Claeys Y, Schurmans C, De Crop M, Menten J, Ravinetto R, Thriemer K, Van Geertruyden JP, Mutabingwa T, D'Alessandro U; Pregact Group.

Reprod Health. 2015 Jan 15;12:5. doi: 10.1186/1742-4755-12-5.

40.

Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.

Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, Hachizovu S, Asadu E, Tuho MZ, Ettiegne-Traore V, Mbofana F, Okello V, Azih C, Denison JA, Tsui S, Koole O, Kamiru H, Nuwagaba-Biribonwoha H, Alfredo C, Jobarteh K, Odafe S, Onotu D, Ekra KA, Kouakou JS, Ehrenkranz P, Bicego G, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro T, Dukes Hamilton C, Swaminathan M, Dokubo EK, Baughman AL, Spira T, Colebunders R, Bangsberg D, Marlink R, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1097-103.

41.

Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.

Sagara I, Oduro AR, Mulenga M, Dieng Y, Ogutu B, Tiono AB, Mugyenyi P, Sie A, Wasunna M, Kain KC, Djimdé AA, Sarkar S, Chandra R, Robbins J, Dunne MW.

Malar J. 2014 Nov 25;13:458. doi: 10.1186/1475-2875-13-458.

42.

Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.

Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi YD, Colebunders R, Bangsberg DR, van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J.

Trop Med Int Health. 2014 Dec;19(12):1397-410. doi: 10.1111/tmi.12386. Epub 2014 Sep 17.

43.

Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey.

Nambozi M, Malunga P, Mulenga M, Van Geertruyden JP, D'Alessandro U.

Malar J. 2014 Jun 5;13:220. doi: 10.1186/1475-2875-13-220.

44.

Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial.

Manyando C, Njunju EM, Mwakazanga D, Chongwe G, Mkandawire R, Champo D, Mulenga M, De Crop M, Claeys Y, Ravinetto RM, van Overmeir C, Alessandro UD, Van Geertruyden JP.

PLoS One. 2014 May 15;9(5):e96017. doi: 10.1371/journal.pone.0096017. eCollection 2014.

45.

High burden of malaria following scale-up of control interventions in Nchelenge District, Luapula Province, Zambia.

Mukonka VM, Chanda E, Haque U, Kamuliwo M, Mushinge G, Chileshe J, Chibwe KA, Norris DE, Mulenga M, Chaponda M, Muleba M, Glass GE, Moss WJ.

Malar J. 2014 Apr 23;13:153. doi: 10.1186/1475-2875-13-153.

46.

Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.

Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, Mulenga M, Mbacham WF, Roper C, Guerin PJ, D'Alessandro U, Snow RW.

Lancet Infect Dis. 2012 Nov;12(11):888-96. doi: 10.1016/S1473-3099(12)70241-4. Review.

47.

Challenges and prospects for malaria elimination in the Southern Africa region.

Moss WJ, Norris DE, Mharakurwa S, Scott A, Mulenga M, Mason PR, Chipeta J, Thuma PE; Southern Africa ICEMR Team.

Acta Trop. 2012 Mar;121(3):207-11. doi: 10.1016/j.actatropica.2011.06.019. Epub 2011 Aug 19.

48.

Malaria epidemiology and control in Southern Africa.

Mharakurwa S, Thuma PE, Norris DE, Mulenga M, Chalwe V, Chipeta J, Munyati S, Mutambu S, Mason PR; Southern Africa ICEMR Team.

Acta Trop. 2012 Mar;121(3):202-6. doi: 10.1016/j.actatropica.2011.06.012. Epub 2011 Jul 2.

49.

Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae.

Cirimotich CM, Dong Y, Clayton AM, Sandiford SL, Souza-Neto JA, Mulenga M, Dimopoulos G.

Science. 2011 May 13;332(6031):855-8. doi: 10.1126/science.1201618.

50.

Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.

Nambozi M, Van Geertruyden JP, Hachizovu S, Chaponda M, Mukwamataba D, Mulenga M, Ubben D, D'Alessandro U.

Malar J. 2011 Feb 28;10:50. doi: 10.1186/1475-2875-10-50.

Supplemental Content

Loading ...
Support Center